Skip to main content
OpenTrials
Completed

NCT Number: NCT00492895

Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients

Photosensitivity of the skin to UVA and UVB will be determined

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Clinic for Dermatology, University Hospital of Zurich

Zurich, Switzerland

About this study

Photosensitivity of the skin to UVA and UVB in renal transplant recipients with and without azathioprine will be determined. Azathioprine will be discontinued and photosensitivity determined after a wash-out period of three months

  • Trial with medicinal product

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Renal transplant recipients under azathioprin

Exclusion criteria

  • Treatment with Prograf (Tacrolimus)

Treatment and study plan

Discontinuation of Azathioprin

Drug

Discontinuation of Azathioprin

Primary outcomes

  1. Photosensitivity of the skin to UVA and UVB

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Important dates

Study start
2007
Primary completion
2010
Study completion
2011
First posted
Jun 27, 2007
Registry last updated
Jan 29, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.